| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pacira Biosciences, Inc. (PCRX) has 15 insiders with recent SEC Form 4 filings, including 3 buys and 10 sells. PCRX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 399.0K | $9.38M | - | |
| Other | 218.9K | $5.15M | - | |
| Other | 167.1K | $3.93M | -10,259 | |
| CFO | 118.3K | $2.78M | - | |
| VP | 62.3K | $1.46M | -6,115 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 6, 2016 | Williams Kristen Marie76 | CAO And General Counsel | Sell | 600 | $47.20 | $28,319.40 | -8.0% | |
| Jun 6, 2016 | Kronenfeld Mark A. | Director | Sell | 900 | $46.95 | $42,255.00 | -23.4% | |
| Jun 6, 2016 | Brege Laura62 | Director | Sell | 1,000 | $46.95 | $46,950.00 | -50.0% | |
| Jun 6, 2016 | Hastings Paul J77 | Director | Sell | 1,136 | $46.95 | $53,335.20 | -39.8% | |
| Apr 15, 2016 | Stack David M67 | CEO And Chairman | Sale+OE | 25,000 | $64.14 | $1,603,377.50 | -78.3% | |
| Feb 17, 2016 | Hastings Paul J77 | Director | Sale+OE | 3,000 | $60.00 | $180,000.00 | -51.3% | |
| Jan 29, 2016 | Braunstein Scott | SVP, Strategy &Corp. Dev. | Buy | 2,000 | $58.92 | $117,840.00 | New | |
| Jan 27, 2016 | Jones James B | SVP &Chief Medical Officer | Buy | 500 | $62.50 | $31,250.00 | +50.0% | |
| Jan 15, 2016 | Stack David M67 | CEO And Chairman | Sale+OE | 15,000 | $63.84 | $957,591.84 | -43.8% | |
| Jan 12, 2016 | Jones James B | SVP &Chief Medical Officer | Buy | 1,000 | $66.00 | $66,000.00 | New |